EU publishes new drafts of patient information and pharmacovigilance proposals
This article was originally published in SRA
The European Commission has published the revised proposals on pharmacovigilance and information to patients, following its decision on 2 December last year to separate the two1. The two proposals, which each take the form of a draft directive and draft regulation, have now been sent to the European Parliament and the Council of Ministers for discussion.
You may also be interested in...
The pharmaceutical industry and other stakeholders have taken part in the launch event for a new initiative intended to tackle issues that have been amplified by the COVID-19 pandemic, such as supply chain resilience and medicine shortages. The project has drawn a mixed response from industry bodies.
The MHRA is losing no time in getting its much heralded “new era” of medicines regulation up and running.
Coronavirus Notebook: EMA Issues Guidance On Development Of Variant Vaccines, EU Leaders Urge Production Ramp-Up
A batch of AstraZeneca/Oxford University coronavirus vaccines has arrived in Ghana, the first country in the world to receive vaccines via the COVAX Facility.